Dynavax Technologies Corp (NASDAQ: DVAX) has reported earnings for its third fiscal quarter (ending September 30) of $0.11 versus $0.50 for the same period a year ago — a decline of -78%. However, this result exceeded the consensus estimate of $0.01 by $0.10. For the latest four quarters through September 30, E.P.S. were $0.48 versus $2.59 for the same period a year ago — a decline of -81%.
Recent Price Action
On 11/2/23, Dynavax Technologies Corp (NASDAQ: DVAX) stock declined slightly by -0.2%, closing at $14.07. The stock has risen 0.9% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
DVAX is expected to be a modest Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
Dynavax Technologies has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Dynavax Technologies has a poor Appreciation Score of 19 but a very high Power Rating of 93, triggering the Neutral Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment